Exelixis, Inc.
EXEL · NASDAQ
1/3/2025 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,169 | $1,830 | $1,611 | $1,435 |
| % Growth | 18.5% | 13.6% | 12.3% | – |
| Cost of Goods Sold | $76 | $73 | $58 | $53 |
| Gross Profit | $2,092 | $1,758 | $1,553 | $1,382 |
| % Margin | 96.5% | 96% | 96.4% | 96.3% |
| R&D Expenses | $910 | $1,044 | $892 | $694 |
| G&A Expenses | $492 | $543 | $418 | $370 |
| SG&A Expenses | $492 | $543 | $460 | $402 |
| Sales & Mktg Exp. | $0 | $0 | $42 | $32 |
| Other Operating Expenses | $85 | $0 | -$0 | -$0 |
| Operating Expenses | $1,488 | $1,587 | $1,352 | $1,095 |
| Operating Income | $605 | $171 | $201 | $287 |
| % Margin | 27.9% | 9.3% | 12.5% | 20% |
| Other Income/Exp. Net | $77 | $87 | $33 | $7 |
| Pre-Tax Income | $682 | $258 | $234 | $294 |
| Tax Expense | $160 | $50 | $52 | $63 |
| Net Income | $521 | $208 | $182 | $231 |
| % Margin | 24% | 11.4% | 11.3% | 16.1% |
| EPS | 1.8 | 0.65 | 0.57 | 0.73 |
| % Growth | 176.9% | 14% | -21.9% | – |
| EPS Diluted | 1.76 | 0.65 | 0.56 | 0.72 |
| Weighted Avg Shares Out | 290 | 318 | 322 | 315 |
| Weighted Avg Shares Out Dil | 296 | 321 | 325 | 322 |
| Supplemental Information | – | – | – | – |
| Interest Income | $77 | $87 | $33 | $8 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $29 | $26 | $21 | $14 |
| EBITDA | $719 | $197 | $222 | $300 |
| % Margin | 33.1% | 10.7% | 13.8% | 20.9% |